We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Virotec Intl | LSE:VTI | London | Ordinary Share | GB00B15PVR02 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 12.50 | 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
RNS Number : 4023U
Virotec International PLC
14 May 2008
Virotec International plc
14 May 2008
Virotec International plc ("Virotec" or the "Company")
Posting of Scheme Document and Annual Report and Accounts
On 7 May 2008 the Virotec Independent Directors and Hydrodec Independent Directors confirmed that they had conditionally agreed the
terms of a recommended acquisition of Virotec whereby Hydrodec Group plc ("Hydrodec") will acquire, for shares and cash, the entire issued
and to be issued ordinary share capital of Virotec, to be effected by means of a scheme of arrangement under sections 895 to 901 of the
Companies Act 2006 (the "Scheme").
Virotec announces that a circular (the "Scheme Document"), which sets out the full terms and conditions of the Scheme and an explanatory
statement, together with the action to be taken by Virotec shareholders, has been posted to Virotec`s shareholders.
Subject to the satisfaction or waiver of the relevant conditions it is currently expected that the Scheme will become effective on 25
June 2008.
Capitalised terms used, but not defined, in this announcement have the same meanings as given to them in the Scheme Document.
Additionally, Virotec announces that its annual report and accounts for the year ended 31 December 2007 has been posted to shareholders
and will shortly be made available for viewing on the Company's website (www.virotec.com) or from:
The Secretary
PO Box 1092
Oxenford
Queensland 4210
Australia
Tel: + 61 7 5573 3353
Enquiries
Virotec International plc +61 755 733 353
Angus Craig
Arden Partners plc +44 (0) 20 7398 1600
Christopher Hardie
Matthew Armitt
This information is provided by RNS
The company news service from the London Stock Exchange
END
OUPUSAKRWNRVARR
1 Year Virotec Chart |
1 Month Virotec Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
